微芯科技

Microchip Technology: JP Morgan Maintains Overweight, Raises PT to $95 from $85

Citigroup Maintains Buy Rating for Microchip Technology, PT Down to $91

Microchip Technology: Wells Fargo Raises PT to $70 from $68, Maintains Equal-Weight Rating

Microchip Technology: Truist Securities Raises PT to $68 from $60, Maintains Hold Rating

Cantor Fitzgerald Raises PT on Microchip Technology to $100, Reiterates Overweight Rating

Catalyst<ul> <li>Recent Bullish Engulfing and MACD Death Cross signals in late January to early February 2026 indicate potential bullish momentum for MCHP.</li> <li>Most analysts rate MCHP Buy or Strong Buy, showing broad institutional optimism.</li> <li>The company maintains strong cash reserves and interest coverage ratio, indicating solid financial health.</li></ul>Risk<ul> <li>Fund flow analysis shows overall negative net inflow, with large and extra-large order sizes trending negatively.</li> <li>Technical indicators show the market is in a volatile state with no clear directional bias, suggesting continued uncertainty for MCHP.</li></ul>

Key Factors

Microchip Technology (MCHP) reported Q3 FY26 net sales of $1.186 billion, a 15.6% year-over-year increase and 4.0% sequential growth.MCHP raised Q4 2026 revenue guidance to $1.26 billion, citing sustained momentum in automotive, industrial, and data center markets.Microchip's Q3 non-GAAP earnings per share were $0.44, exceeding estimates by 3.38%, and net income turned positive at $62.7 million.MCHP's stock fell 2.60% on February 6, 2026, following downward Q4 revenue guidance below Wall Street expectations and heightened investor concerns over the semiconductor industry's challenges.Microchip Technology received Frost & Sullivan's 2025 Global Product Leadership Recognition for its automotive touchscreen controllers, highlighting innovation and engineering excellence.

MCHP News